Evaluation of 5-Fluorouracil Pharmacokinetics in Cancer Patients with a c.1905+1G>A Mutation in DPYD by Means of a Bayesian Limited Sampling Strategy

Author： van Kuilenburg André B.P.

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.51, Iss.3, 2012-03, pp. : 163-174

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of 5-fluorouracil pharmacokinetic models and therapeutic drug monitoring in cancer patients

By van Kuilenburg André BP Maring Jan Gerard

Pharmacogenomics, Vol. 14, Iss. 7, 2013-05 ,pp. : 799-811

Future Medicine

Access to resources Recommend Favorite

Capecitabine/fluorouracil: Cardiotoxicity in a patient with a novel DPYD gene mutation: case report

Reactions Weekly, Vol. 1, Iss. 1259, 2009-01 ,pp. : 12-13

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetics and Dosing Recommendations for Cisplatin during Intraperitoneal Peroperative Administration: Development of a Limited Sampling Strategy for Toxicity Risk Assessment

By Royer Bernard Jullien Vincent

Clinical Pharmacokinetics, Vol. 48, Iss. 3, 2009-01 ,pp. : 169-180

Adis International

Access to resources Recommend Favorite

Capecitabine versus Bolus Fluorouracil plus Leucovorin (Folinic Acid) as Adjuvant Chemotherapy for Patients with Dukes' C Colon Cancer: Economic Evaluation in an Italian NHS Setting

By Francesco Di Costanzo

Clinical Drug Investigation, Vol. 28, Iss. 10, 2008-01 ,pp. : 645-655

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Study of Mycophenolate Mofetil in Patients with Systemic Lupus Erythematosus and Design of Bayesian Estimator Using Limited Sampling Strategies

By Zahr Noël

Clinical Pharmacokinetics, Vol. 47, Iss. 4, 2008-01 ,pp. : 277-284

Adis International

Access to resources Recommend Favorite